Randomised phase II trial of cabozantinib as second-line therapy in patients with non-small cell lung cancer.
Latest Information Update: 04 May 2012
At a glance
- Drugs Cabozantinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 May 2012 New trial record